With Exopol from Spain and INVAC from Germany Klaus-Peter Behr, Chairman, could welcome two new members at the 8th ordinary General Assembly on 19th of April.
At an EMAV workshop in Vienna end of April experts from the EMAV members and highly esteemed scientists shared information about conditions and appropriate methods in the control of animal diseases and zoonoses. The evaluation of the situation in Europe demonstrates the significant as fast growing importance of veterinary vaccines and highlights the indispensable role of esp. Autogenous vaccines (AV) as an valuable tool in the hands of veterinary practitioners. This analysis is supporting the optimal use of AV in terms of animal health management, the reduction in use of antibiotics and the prevention of animal diseases and zoonoses.
The report of the common IABS - EMAV meeting about Autogenous vaccines, held on 14-16 September in Munich, is available at the scientific journal BIOLOGICALS (Volume 76, April 2022, Pages 36-41)
Recently the IABS “Conclusion and Recommendation” of the Munich conference about “Autogenous Vaccines: quality of production and movement in a common market” have been published at the IABS congress website.
The European Affiliate of the International Alliance for Biological Standardization (IABS-EU) and the Association of European Manufacturers of Autogenous Vaccines & Sera (EMAV) have confirmed the Meeting “Autogenous Vaccines: Quality of Production and Movement in a Common Market” from the 14th to 16th of September, 2021 at Ludwig Maximilian University in Munich, Germany.